|
|
|
|
Office Locations:
|
40 Broad Street, Suite 201
Boston, MA 02109
Phone: 857-254-9500
| |
|
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Vida Ventures is a next-generation life sciences investment firm founded in 2017 by a group of scientists, physicians, entrepreneurs and investors passionate about building and funding breakthroughs in biomedicine. Its mission is to bring science to life and advance transformative biomedical innovations that have the potential to make a meaningful difference for patients. Vida has a bicoastal presence and currently manages approximately $1 billion. Vida Ventures can build and back companies regardless of stage and across therapeutic areas.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
|
|
| Name | |
| |
Title | |
|
| Arie Belldegrun | |
M.D. | |
Co-Founder, Sr. Managing Director | |
| Arjun Goyal | |
M.D., M.Phil, M.B.A. | |
Co-Founder, Managing Director | |
| David Chang | |
M.D., Ph.D. | |
Scientific Advisor | |
| Fred Cohen | |
M.D., D.Phil | |
Co-founder & Senior Advisor | |
| Helen Kim | |
M.B.A. | |
Senior Managing Director | |
|
|
|
|
|
|
|
|
|
